Intel, benefiting from strong sentiment during Wednesday’s session and news of a partnership with Google, rose by more than 11%. The share price reached $59, approaching the highs from 2020 and 2000.
Google, part of Alphabet, announced that it will use the latest Xeon series processors manufactured by Intel. Intel’s CEO, Lip-Bu Tan, emphasized during the conference the flexibility offered by the new processor lineup, which, he stressed, is crucial for operations focused on artificial intelligence.
This is not the only significant commitment to Intel in recent days. On Tuesday, the company announced that it would join Elon Musk’s “Terafab” initiative. It is a data-center complex intended to support Tesla and SpaceX efforts in artificial intelligence and robotics.
However, the positive news for the company is not limited to declarations alone. Intel has managed to buy back its Xeon processor plant in Ireland, which it previously had to sell to Apollo Global Management.
INTC.US (D1)
The price continues an increasingly steep uptrend. The crossover of the EMA100 and EMA200 clearly signaled an upward wave, and momentum is accelerating. The price broke decisively above the resistance zone around $56, opening the way for a test of the $68 level. Source: xStation5.
Daily summary: Nervous anticipation, SaaS sell-off and weak macro data
โSaaS-pocalypseโ continued
US OPEN: The market calms down ahead of earnings season
Globalstar: Are we headed for a battle of giants over orbit?
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
